Delivery Order SPE2DB22D2006-SPE2DB25FV8EK
Award Date
2/5/25
Potential Completion Date
2/6/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.00 firm fixed-price delivery order is for the medication Emgality 120 mg/ml pen injector, and has a completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is for the delivery of the pharmaceutical product Emgality 120 mg/ml penml to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $1,884.63, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,416.16 firm-fixed-price delivery order is for the supply of Emgality 120 mg/ml pen injector medication, with a period of performance through July 12, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Emgality 120 mg/ml pens. The $2,361.84 firm-fixed-price delivery order contract has a period of performance through December 27, 2024. The award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order valued at $6,992.72 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Emgality 120 mg/ml pens. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of Emgality 120 mg/ml pens. The contract has a ceiling value of $2,593.50 and is a firm fixed-price delivery order with a completion date of January 15, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,002.72, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the pharmaceutical product Emgality 120 mg/mL pen, with a performance period through April 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor on an indefinite delivery contract (IDC) with DLA,...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emgality 120 mg/ml pens, a medication used for the treatment of migraines. The contract has a ceiling value of $1,124.81 and runs through February 16, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and...
This federal contract award is for the delivery of the pharmaceutical product Emgality 120 mg/ml, awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract has a ceiling value of $1,671.20 and a completion date of July 1, 2024. It was awarded on June 28, 2024 by the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of Emgality 120 mg/ml injectable medication to the Defense Logistics Agency (DLA). The $1,669.08 firm fixed-price delivery order was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 17, 2023. The contract has an ultimate completion date of January 18, 2023 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...